Home - MS Research Australia
Seed Funded World First Blood Biomarker for MS Types
29 November, 2019

In MS, the immune system damages the insulating coating on nerve cells known as myelin. The human body […]

13 November, 2019

The first ever treatment for secondary progressive MS, a form of MS that can follow on from relapsing remitting MS, has been approved in Australia.

29 October, 2019

The Federal Government has expanded the PBS listing of fingolimod (Gilenya) and natalizumab (Tysabri) to include younger people. […]

The Australian MS Longitudinal Study

The Australian MS Longitudinal Study (AMSLS) is a long-term, survey-based, tracking study collecting data of practical use for improving the lives of Australians living with MS.

MS Research Australia Clinical Trials Network

The MS Research Australia Clinical Trials Network connects trial sponsors and clinical research organisations with potential trial sites, health professionals and people with MS in Australia and New Zealand.

Vitamin D MS Prevention Trial - PrevANZ

The vitamin D MS Prevention Trial is a clinical trial that will test whether vitamin D supplementation can prevent MS in those at risk of developing the disease.

MS Research Australia Brain Bank

The MS Research Australia Brain Bank coordinates the collection, storage and distribution of neurological tissue from people with MS for use in research.

Professor Mary Galea
The University of Melbourne, VIC

GRANT TYPE:

Project

Dr Steven Petratos
Monash University, VIC

GRANT TYPE:

Incubator

Associate Professor Anthony Don
The University of Sydney, NSW

GRANT TYPE:

Incubator

Dr Lucinda Black
Curtin University, WA

GRANT TYPE:

Travel Award

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search